This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:
New survey data released today by the World Health Organization (WHO) show that most countries have developed plans to address antimicrobial resistance (AMR). But few have implemented or provided financing for those plans.
The data, from the Tracking AMR Self-assessment Survey (TRaCSS), conducted every year by the WHO and other international agencies engaged in the fight against drug-resistant infections, show that 179 countries (89% of WHO member states) have developed a national AMR action plan, up from 79 (41%) in 2017. But only 42 (22%) have translated those plans into funded programs.
National action plans have been a cornerstone of the WHO's efforts to address AMR since the United Nations (UN) High-Level Meeting on AMR in 2016. At the follow-up meeting in 2024, member states agreed that, by 2030, at least 60% of countries should have funded AMR action plans.
WHO technical officer Pravarsha Prakash, MS, said at a media briefing this morning that while the number of nations with an AMR action plan shows real progress, "countries now also need to move from plans to delivery."
Jean Pierre Nyemazi, MD, acting director of the WHO's AMR Department, said the world is in a pivotal moment in the fight against drug-resistant infections, which were responsible for more than 1 million deaths and contributed to nearly 5 million in 2021.
"The choices we make now will determine whether future generations inherit a world where common infections are treatable," Nyemazi said.
Source link







